Mitochondrial dysfunction in obesity: Potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome

被引：55
作者：
Alam M.A. [1 ,2 ]
Rahman M.M. [2 ]
机构：
[1] School of Biomedical Science, The University of Queensland, Brisbane
[2] Department of Pharmaceutical Sciences, North South University, Dhaka
来源：
Journal of Diabetes & Metabolic Disorders | / 13卷 / 1期
关键词：
Co-enzyme Q10; Inflammation; Metabolic syndrome; Obesity; Oxidative stress;
D O I：
10.1186/2251-6581-13-60
中图分类号：
学科分类号：
摘要：
Co-enzyme Q10 (Co-Q10) is an essential component of the mitochondrial electron transport chain. Most cells are sensitive to co-enzyme Q10 (Co-Q10) deficiency. This deficiency has been implicated in several clinical disorders such as heart failure, hypertension, Parkinson's disease and obesity. The lipid lowering drug statin inhibits conversion of HMG-CoA to mevalonate and lowers plasma Co-Q10 concentrations. However, supplementation with Co-Q10 improves the pathophysiological condition of statin therapy. Recent evidence suggests that Co-Q10 supplementation may be useful for the treatment of obesity, oxidative stress and the inflammatory process in metabolic syndrome. The anti-inflammatory response and lipid metabolizing effect of Co-Q10 is probably mediated by transcriptional regulation of inflammation and lipid metabolism. This paper reviews the evidence showing beneficial role of Co-Q10 supplementation and its potential mechanism of action on contributing factors of metabolic and cardiovascular complications. © 2014 Alam and Rahman; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 147 条
[1]  
Huang P.L., A comprehensive definition for metabolic syndrome, Dis Model Mech, 2, pp. 231-237, (2009)
[2]  
Roberts C.K., Sindhu K.K., Oxidative stress and metabolic syndrome, Life Sci, 84, pp. 705-712, (2009)
[3]  
Hopps E., Noto D., Caimi G., Averna M.R., A novel component of the metabolic syndrome: the oxidative stress, Nutr Metab Cardiovasc Dis, 20, pp. 72-77, (2010)
[4]  
Patti M.-E., Corvera S., The role of mitochondria in the pathogenesis of type 2 diabetes, Endocrine Rev, 31, pp. 364-395, (2010)
[5]  
Hotamisligil G.S., Spiegelman B.M., Tumor necrosis factor alpha: a key component of the obesity-diabetes link, Diabetes, 43, pp. 1271-1278, (1994)
[6]  
Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W., Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, pp. 1796-1808, (2003)
[7]  
Savage D.B., Petersen K.F., Shulman G.I., Mechanisms of insulin resistance in humans and possible links with inflammation, Hypertension, 45, pp. 828-833, (2005)
[8]  
Nisoli E., Clementi E., Carruba M.O., Moncada S., Defective mitochondrial biogenesis, Circ Res, 100, pp. 795-806, (2007)
[9]  
Valerio A., Cardile A., Cozzi V., Bracale R., Tedesco L., Pisconti A., Palomba L., Cantoni O., Clementi E., Moncada S., Carruba M.O., Nisoli E., TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents, J Clin Invest, 116, pp. 2791-2798, (2006)
[10]  
Bonakdar R.A., Guarneri E., Coenzyme Q10, Am Fam Physician, 72, pp. 1065-1070, (2005)
12345678910